会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 31. 发明授权
    • Motilide compounds
    • 化合物
    • US06750205B2
    • 2004-06-15
    • US10409429
    • 2003-04-07
    • Gary AshleyMark BurlingameChristopher CarrerasDaniel Santi
    • Gary AshleyMark BurlingameChristopher CarrerasDaniel Santi
    • A61K3170
    • C07H17/08
    • The present invention provides novel macrolide compounds of the formulas wherein: R is hydroxyl or methoxy; R1 is selected from the group consisting of hydrogen, hydroxyl, halide, NH2, OR9, where R9 is C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, aryl or heteroaryl and R10 and R11 are each independently hydrogen, C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, or aryl; R2 and R3 are each independently selected from the group consisting of hydrogen, C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, aryl, alkylaryl, alkenylaryl alkynylaryl or R2 and R3 together form a cycloalkyl or a cycloaryl moiety; R4 is hydrogen or methyl; R5 is hydrogen, hydroxyl, oxo, or together with R6 and the carbons to which they are attached form a cyclic carbonate; R6 is hydrogen, hydroxyl, OR12 where R12 is C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, or together with R5 and the carbons to which they are attached form a cyclic carbonate; R7 is methyl, C3-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, alkylaryl, alkenylaryl, alkynylaryl, amidoalkylaryl, amidoalkenylaryl, or amidoalkynylaryl; R8 is C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, alkylaryl, alkenylaryl, alkynylaryl, amidoalkylaryl, amidoalkenylaryl, or amidoalkynylaryl; and, x is a single or a double bond.
    • 本发明提供下式的新型大环内酯化合物,其中R是羟基或甲氧基; R 1选自氢,羟基,卤素,NH 2,OR 9,其中R 9是C 1 -C 10 烷基,C 2 -C 10烯基,C 2 -C 10炔基,芳基或杂芳基,R 10和R 11各自独立地为氢,C 1 -C 10烷基,C 2 -C 10烯基,C 2 -C 10炔基或芳基; R 2和R 3各自独立地选自氢,C 1 -C 10烷基,C 2 -C 10烯基,C 2 -C 10炔基,芳基,烷基芳基,烯基芳基炔基芳基或R 2和R 3一起 形成环烷基或环芳基部分; R 4是氢或甲基; R 5是氢,羟基,氧代或与R 6一起,并且它们连接的碳形成环状碳酸酯; 其中R 12是C 1 -C 10烷基,C 2 -C 10烯基,C 2 -C 10炔基,或与R 5一起形成的碳原子和它们所连接的碳原子形成环状 碳酸酯; R 7是甲基,C 3 -C 10烷基,C 2 -C 10烯基,C 2 -C 10 炔基,烷基芳基,烯基芳基,炔基芳基,酰氨基烷基芳基,酰氨基烯基芳基或酰胺基炔基芳基; R 8是C 1 -C 10烷基,C 2 -C 10烯基,C 2 -C 10炔基,烷基芳基,链烯基芳基,炔基芳基,酰氨基烷基芳基,酰胺基烯基芳基或酰胺基炔基芳基; x是单键或双键。
    • 37. 发明授权
    • Motilide compounds
    • 化合物
    • US06562795B2
    • 2003-05-13
    • US09788314
    • 2001-02-15
    • Gary AshleyMark BurlingameChristopher CarrerasDaniel Santi
    • Gary AshleyMark BurlingameChristopher CarrerasDaniel Santi
    • A61K3170
    • C07H17/08
    • The present invention provides novel macrolide compounds of the formulas wherein: R is hydroxyl or methoxy; R1 is selected from the group consisting of hydrogen, hydroxyl, halide, NH2, OR9,  where R9 is C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, aryl or heteroaryl and R10 and R11 are each independently hydrogen, C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, or aryl; R2 and R3 are each independently selected from the group consisting of hydrogen, C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, aryl, alkylaryl, alkenylaryl, alkynylaryl or R2 and R3 together form a cycloalkyl or a cycloaryl moiety; R4 is hydrogen or methyl; R5 is hydrogen, hydroxyl, oxo, or together with R6 and the carbons to which they are attached form a cyclic carbonate; R6 is hydrogen, hydroxyl, OR12 where R12 is C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, or together with R5 and the carbons to which they are attached form a cyclic carbonate; R7 is methyl, C3-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, alkylaryl, alkenylaryl, alkynylaryl, amidoalkylaryl, amidoalkenylaryl, or amidoalkynylaryl; R8 is C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, alkylaryl, alkenylaryl, alkynylaryl, amidoalkylaryl, amidoalkenylaryl, or amidoalkynylaryl; and, x is a single or a double bond.
    • 本发明提供下式的新型大环内酯化合物,其中R为羟基或甲氧基; R 1选自氢,羟基,卤素,NH 2,OR 9,其中R 9为C 1 -C 10烷基,C 2 -C 10烯基, C10炔基,芳基或杂芳基,R10和R11各自独立地为氢,C1-C10烷基,C2-C10烯基,C2-C10炔基或芳基; R2和R3各自独立地选自氢,C1-C10 烷基,C 2 -C 10烯基,C 2 -C 10炔基,芳基,烷基芳基,烯基芳基,炔基芳基或R 2和R 3一起形成环烷基或环芳基部分; R 4是氢或甲基; R 5是氢,羟基,氧代或与R 6一起 并且与它们相连的碳原子形成环状碳酸酯; R 6是氢,羟基,OR 12,其中R 12是C 1 -C 10烷基,C 2 -C 10烯基,C 2 -C 10炔基,或与R 5和它们所连接的碳一起 形成环状碳酸酯; R 7是甲基,C 3 -C 10烷基,C 2 -C 10烯基,C 2 -C 10炔基,烷基芳基,链烯基芳基 ,芳基芳基,酰氨基烷基芳基,酰胺基烯基芳基或酰氨基炔基芳基; R8是C1-C10烷基,C2-C10烯基,C2-C10炔基,烷基芳基,烯基芳基,炔基芳基,酰氨基烷基芳基,酰氨基烯基芳基或酰胺基炔基芳基; x是单键或双键。
    • 38. 发明授权
    • Epothilone derivatives and methods for making and using the same
    • 埃坡霉素衍生物及其制备和使用方法
    • US06489314B1
    • 2002-12-03
    • US09825856
    • 2001-04-03
    • Gary AshleyBrian Metcalf
    • Gary AshleyBrian Metcalf
    • A61K3133
    • C07D405/06C07D313/00C07D413/06C07D417/06C07D491/04C12N1/20C12N9/00C12N15/52C12N15/74C12P17/16C12P17/181C12R1/01
    • The present invention relates to 16-membered macrocyclic compounds. In one aspect of the present invention, compounds of the formula are provided wherein: R1, R2, R3, and R5 are each independently hydrogen, C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, aryl or alkylaryl; R4 is hydrogen, halogen, C1-C10 alkyl, C1-C10 hydroxyalkyl, C1-C10 haloalkyl, aryl, —C(═O)R6, —C(═O)OR6, —NR6R7 where R6 and R7 are each independently hydrogen, C1-C10 aliphatic, aryl or alkylaryl; W is O, NR8 where R8 is hydrogen, C1-C10 alkyl, C2-C10 alkenyl, C2-C10 alkynyl, aryl or alkylaryl; X is O, CH2 or a carbon-carbon double bond; Y is absent or a C1-C10 alkyl, C2-C10 alkenyl, or C2-C10 alkynyl; and Ar is aryl; provided that 10,11-dehydroepothilone C is excluded.
    • 本发明涉及16元大环化合物。 在本发明的一个方面,提供下列化合物,其中:R1,R2,R3和R5各自独立地为氢,C1-C10烷基,C2-C10烯基,C2-C10炔基,芳基或烷基芳基; R4为氢 卤素,C 1 -C 10烷基,C 1 -C 10羟基烷基,C 1 -C 10卤代烷基,芳基,-C(= O)R 6,-C(= O)OR 6,-NR 6 R 7,其中R 6和R 7各自独立地为氢, 脂族,芳基或烷基芳基; W是O,NR8,其中R8是氢,C1-C10烷基,C2-C10烯基,C2-C10炔基,芳基或烷基芳基; X是O,CH2或碳 - 碳双键; Y是 不存在或C 1 -C 10烷基,C 2 -C 10烯基或C 2 -C 10炔基; 且Ar为芳基; 条件是排除了10,11-脱氢抗坏血酸酮C.
    • 39. 发明授权
    • Macrolide antiinfective agents
    • 大环内酯类抗感染药
    • US06395710B1
    • 2002-05-28
    • US09550045
    • 2000-04-14
    • Daniel T. W. ChuGary Ashley
    • Daniel T. W. ChuGary Ashley
    • A61K3170
    • C07H17/08Y02P20/55
    • Compounds of the formula wherein Ra is H; substituted or unsubstituted alkyl (1-10C); substituted or unsubstituted alkenyl (2-10C); substituted or unsubstituted alkynyl (2-10C); substituted or unsubstituted aryl (4-14C); substituted or unsubstituted arylalkyl (5-20); or ORa is replaced by H; Rb is H or halogen; Rc is H or a protecting group; Rd is methyl, unsubstituted alkyl (3-10C); substituted alkyl (1-10C); substituted or unsubstituted alkynyl (2-10C); substituted or unsubstituted aryl (4-14C); substituted or unsubstituted arylalkyl (5-20C); substituted or unsubstituted arylalkenyl (5-20C); substituted or unsubstituted arylalkynyl (5-20C); substituted or unsubstituted amidoarylalkyl (5-20C); substituted or unsubstituted amidoarylalkenyl (5-20C); or substituted or unsubstituted amidoarylalkynyl (5-20C); Re is H or a protecting group; L is methylene or carbonyl; T is —O—, —N(R)—, —N(OR)—, —N(NHCOR)—, —N(N═CHR)—, or —N(NHR)— wherein R is H or Ra as defined above, with the proviso that when L is methylene, T is —O—; one of Z and Y is H and the other is OH, protected OH, or amino, mono- or dialkylamino, protected amino, or an amino heterocycle or Z and Y together are ═O, ═NOH or a derivatized oxime; including any pharmaceutically acceptable salts thereof and any stereoisomeric forms and mixtures of stereoisomeric forms thereof, are antimicrobial agents.
    • 化学式R a的化合物是H; 取代或未取代的烷基(1-10C); 取代或未取代的烯基(2-10C); 取代或未取代的炔基(2-10C); 取代或未取代的芳基(4-14C); 取代或未取代的芳烷基(5-20​​); 或ORa被H代替; Rb是H或卤素; Rc是H或保护基; Rd是甲基,未取代的烷基(3-10C); 取代的烷基(1-10C); 取代或未取代的炔基(2-10C); 取代或未取代的芳基(4-14C); 取代或未取代的芳基烷基(5-20​​℃); 取代或未取代的芳基烯基(5-20​​℃); 取代或未取代的芳基炔基(5-20​​℃); 取代或未取代的酰氨基芳基烷基(5-20​​℃); 取代或未取代的酰氨基芳基烯基(5-20​​℃); 或取代或未取代的酰氨基芳基炔基(5-20​​℃); Re是H或保护基; L是亚甲基或羰基; T是-O-,-N(R) - , - N(OR) - , - N(NHCOR) - ,-N(N = CHR) - 或-N(NHR) - ,其中R是如上定义的H或Ra,条件是当L是亚甲基时,T是-O-; Z和Y之一是H 另一个是OH,保护的OH或氨基,单或二烷基氨基,保护的氨基或氨基杂环,或Z和Y一起为= O,= NOH或衍生的肟;包括其任何药学上可接受的盐和任何立体异构形式, 其立体异构形式的混合物是抗微生物剂。